Chemoinformaics analysis of Cinncassiol D1 glucoside
| Molecular Weight | 374.345 | nRot | 5 |
| Heavy Atom Molecular Weight | 356.201 | nRig | 18 |
| Exact Molecular Weight | 374.1 | nRing | 3 |
| Solubility: LogS | -3.697 | nHRing | 1 |
| Solubility: LogP | 2.827 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 17 |
| nHA | 8 | APOL | 50.1483 |
| nHD | 2 | BPOL | 27.6057 |
| QED | 0.702 |
| Synth | 2.663 |
| Natural Product Likeliness | 1.4 |
| NR-PPAR-gamma | 0.632 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0 |
| HIA | 0.019 |
| CACO-2 | -4.817 |
| MDCK | 0.0000256 |
| BBB | 0.007 |
| PPB | 0.856265 |
| VDSS | 0.864 |
| FU | 0.189886 |
| CYP1A2-inh | 0.398 |
| CYP1A2-sub | 0.977 |
| CYP2c19-inh | 0.256 |
| CYP2c19-sub | 0.691 |
| CYP2c9-inh | 0.806 |
| CYP2c9-sub | 0.805 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.318 |
| CYP3a4-inh | 0.396 |
| CYP3a4-sub | 0.46 |
| CL | 2.563 |
| T12 | 0.605 |
| hERG | 0.23 |
| Ames | 0.489 |
| ROA | 0.628 |
| SkinSen | 0.256 |
| Carcinogencity | 0.08 |
| EI | 0.826 |
| Respiratory | 0.052 |
| NR-Aromatase | 0.898 |
| Antiviral | Yes |
| Prediction | 0.898449 |